HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 294/2/F450    most recent 00472.2007v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kennedy, D. J. Articles by Shapiro, J. I. Search for Related Content PubMed PubMed Citation Articles by Kennedy, D. J. Articles by Shapiro, J. I.

INNOVATIVE METHODOLOGY

Partial nephrectomy as a model for uremic cardiomyopathy in the mouse

Departments of ¹Medicine and Pharmacology, University of Toledo College of Medicine, Toledo, Ohio; and ²Laboratory of Cardiovascular Science, National Institute on Aging, Baltimore, Maryland

Submitted 11 October 2007 ; accepted in final form 20 November 2007

Because of the plethora of genetic manipulations available in the mouse, we performed a partial nephrectomy in the mouse and examined whether the phenotypical features of uremic cardiomyopathy described in humans and rats were also present in the murine model. A nephrectomy was performed using a combination of electrocautory to decrease renal mass on the left kidney and right surgical nephrectomy. This procedure produced substantial and persistent hypertension as well as increases in circulating concentrations of marinobufagenin. Invasive physiological measurements of cardiac function demonstrated that the nephrectomy resulted in impairment of both active and passive left ventricular relaxation at 4 wk whereas tissue Doppler imaging detected changes in diastolic function after 6 wk. Morphologically, hearts demonstrated enlargement and progressive fibrosis, and biochemical measurements demonstrated downregulation of the sarcoplasmic reticulum calcium ATPase as well as increases in collagen-1, fibronectin, and vimentin expression. Our results suggest that partial nephrectomy in the mouse establishes a model of uremic cardiomyopathy which shares phenotypical features with the rat model as well as patients with chronic renal failure.

renal failure; TGF-β; cardiotonic steroids; reactive oxygen species; fibrosis

This article has been cited by other articles:

				A. N. Wansapura, V. Lasko, Z. Xie, O. V. Fedorova, A. Y. Bagrov, J. B Lingrel, and J. N. Lorenz Marinobufagenin enhances cardiac contractility in mice with ouabain-sensitive {alpha}1 Na+-K+-ATPase Am J Physiol Heart Circ Physiol, June 1, 2009; 296(6): H1833 - H1839. [Abstract] [Full Text] [PDF]

				J. Elkareh, S. M. Periyasamy, A. Shidyak, S. Vetteth, J. Schroeder, V. Raju, I. M. Hariri, N. El-Okdi, S. Gupta, L. Fedorova, et al. Marinobufagenin induces increases in procollagen expression in a process involving protein kinase C and Fli-1: implications for uremic cardiomyopathy Am J Physiol Renal Physiol, May 1, 2009; 296(5): F1219 - F1226. [Abstract] [Full Text] [PDF]

				W. Schoner and G. Scheiner-Bobis Role of endogenous cardiotonic steroids in sodium homeostasis Nephrol. Dial. Transplant., September 1, 2008; 23(9): 2723 - 2729. [Full Text] [PDF]